Evidence map›Paper›PMID 41657634›Full record

ArticleBioinformation2025

Characterization of

Fehmida Bibi, Muhammad Imran Naseer, Peter Natesan Pushparaj, Absarul Haque, Esam Ibraheem Azhar

Abstract read
In one paragraph

Article in Bioinformation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fehmida BibiSpecial Infectious Agents Unit-BSL3, King Fahd Medical Research Centre, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.
Muhammad Imran NaseerInstitute of Genomic Medicine Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Peter Natesan PushparajInstitute of Genomic Medicine Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Absarul HaqueDepartment of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.
Esam Ibraheem AzharSpecial Infectious Agents Unit-BSL3, King Fahd Medical Research Centre, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Halophytes are remarkable plants that have evolved unique strategies to thrive in saline environments. Microbial communities of halophytes are being studied extensively as potential sources of bioactive compounds. Therefore, it is of interest to identify the secondary metabolites of the rhizospheric bacterial

Indexed as

16S rRNA gene sequencebioactive compoundsDesertihabitans sp. FB5Halophytemass spectrometry

Identifiers

PMID41657634
PMCPMC12880122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.